China Universal Asset Management Co., Ltd. Syndax Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,282 shares of SNDX stock, worth $283,424. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,282
Previous 17,121
0.94%
Holding current value
$283,424
Previous $210,000
23.33%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding SNDX
# of Institutions
247Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$140 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$130 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$95.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$82.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$66.7 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $928M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...